Triple

T13786173
Position Surface form Disambiguated ID Type / Status
Subject Ryan Haight E331261 entity
Predicate hasNameGivenTo P94429 FINISHED
Object Ryan Haight Online Pharmacy Consumer Protection Act of 2008 E65826 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Ryan Haight Online Pharmacy Consumer Protection Act of 2008 | Statement: [Ryan Haight, hasNameGivenTo, Ryan Haight Online Pharmacy Consumer Protection Act of 2008]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Ryan Haight Online Pharmacy Consumer Protection Act of 2008
Context triple: [Ryan Haight, hasNameGivenTo, Ryan Haight Online Pharmacy Consumer Protection Act of 2008]
  • A. Ryan Haight Online Pharmacy Consumer Protection Act of 2008 chosen
    The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 is a U.S. federal law that regulates internet pharmacies by requiring valid prescriptions and in-person medical evaluations before dispensing controlled substances online.
  • B. Food and Drug Administration Amendments Act of 2007
    The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
  • C. Prescription Drug User Fee Act of 1992
    The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
  • D. Food and Drug Administration Safety and Innovation Act of 2012
    The Food and Drug Administration Safety and Innovation Act of 2012 is a U.S. federal law that reauthorized and expanded FDA user fee programs while enhancing the agency’s authority over drug and medical device safety, innovation, and supply chain oversight.
  • E. Drug Price Competition and Patent Term Restoration Act of 1984
    The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d81c58feb08190a77bca8bf7d6d20f completed April 9, 2026, 9:38 p.m.
NER Named-entity recognition batch_69de0248db988190aa43c3723af25f90 completed April 14, 2026, 9 a.m.
NED1 Entity disambiguation (via context triple) batch_69f7b07d872c81908f912263d8f7c80d completed May 3, 2026, 8:30 p.m.
Created at: April 9, 2026, 10:11 p.m.